K. Honjo, R. Van-reekum, and N. Verhoeff, Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease?, Alzheimer's & Dementia, vol.5, issue.4, pp.348-360, 2009.
DOI : 10.1016/j.jalz.2008.12.001

C. Carter, APP, APOE, complement receptor 1, clusterin and PICALM and their involvement in the herpes simplex life cycle, Neuroscience Letters, vol.483, issue.2, pp.96-100, 2010.
DOI : 10.1016/j.neulet.2010.07.066

C. Carter, Alzheimer's disease plaques and tangles: Cemeteries of a Pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction, Neurochemistry International, vol.58, issue.3, pp.301-320, 2011.
DOI : 10.1016/j.neuint.2010.12.003

M. Wozniak and R. Itzhaki, Antiviral agents in Alzheimer's disease: hope for the future?, Therapeutic Advances in Neurological Disorders, vol.3, issue.3, pp.141-152, 2010.
DOI : 10.1177/1756285610370069

L. Letenneur, K. Peres, H. Fleury, I. Garrigue, and P. Barberger-gateau, Seropositivity to Herpes Simplex Virus Antibodies and Risk of Alzheimer's Disease: A Population-Based Cohort Study, PLoS ONE, vol.25, issue.11, p.3637, 2008.
DOI : 10.1371/journal.pone.0003637.t003

K. Blennow, H. Hampel, M. Weiner, and H. Zetterberg, Cerebrospinal fluid and plasma biomarkers in Alzheimer disease, Nature Reviews Neurology, vol.359, issue.3, pp.131-144, 2010.
DOI : 10.1038/nrneurol.2010.4

J. Lambert, S. Schraen-maschke, F. Richard, N. Fievet, and O. Rouaud, Association of plasma amyloid ?? with risk of dementia: The prospective Three-City Study, Neurology, vol.73, issue.11, pp.847-853, 2009.
DOI : 10.1212/WNL.0b013e3181b78448

F. Song, A. Poljak, M. Valenzuela, R. Mayeux, and G. Smythe, Metaanalysis of plasma amyloid-beta levels in Alzheimer's disease, J Alzheimers Dis, vol.26, pp.365-375, 2011.

J. Lambert, S. Heath, G. Even, D. Campion, and K. Sleegers, Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease, Nature Genetics, vol.12, issue.10, pp.1094-1099, 2009.
DOI : 10.1038/ng.439

R. Itzhaki and M. Wozniak, Herpes simplex virus type 1, apolipoprotein E, and cholesterol: A dangerous liaison in Alzheimer???s disease and other disorders, Progress in Lipid Research, vol.45, issue.1, pp.73-90, 2006.
DOI : 10.1016/j.plipres.2005.11.003

R. Itzhaki and M. Wozniak, Herpes Simplex Virus Type 1 in Alzheimer's Disease: The Enemy Within, Journal of Alzheimer's Disease, vol.13, issue.4, pp.393-405, 2008.
DOI : 10.3233/JAD-2008-13405

K. Blennow, M. De-leon, and H. Zetterberg, Alzheimer's disease, The Lancet, vol.368, issue.9533, pp.387-403, 2006.
DOI : 10.1016/S0140-6736(06)69113-7

URL : https://hal.archives-ouvertes.fr/hal-01098836

S. Cosentino, Y. Stern, E. Sokolov, N. Scarmeas, and J. Manly, Plasma {beta}-Amyloid and Cognitive Decline, Arch Neurol, vol.67, pp.1485-1490, 2010.

D. Devanand, N. Schupf, Y. Stern, R. Parsey, and G. Pelton, Plasma A?? and PET PiB binding are inversely related in mild cognitive impairment, Neurology, vol.77, issue.2, pp.125-131, 2011.
DOI : 10.1212/WNL.0b013e318224afb7

N. Schupf, M. Tang, H. Fukuyama, J. Manly, and H. Andrews, Peripheral A?? subspecies as risk biomarkers of Alzheimer's disease, Proceedings of the National Academy of Sciences, vol.105, issue.37, pp.14052-14057, 2008.
DOI : 10.1073/pnas.0805902105

K. Yaffe, A. Weston, N. Graff-radford, S. Satterfield, and E. Simonsick, Association of Plasma ??-Amyloid Level and Cognitive Reserve With Subsequent Cognitive Decline, JAMA, vol.305, issue.3, pp.261-266, 2011.
DOI : 10.1001/jama.2010.1995

S. Shipley, E. Parkin, R. Itzhaki, and C. Dobson, Herpes simplex virus interferes with amyloid precursor protein processing, BMC Microbiology, vol.5, issue.1, p.48, 2005.
DOI : 10.1186/1471-2180-5-48

S. Cheng, P. Ferland, P. Webster, and E. Bearer, Herpes Simplex Virus Dances with Amyloid Precursor Protein while Exiting the Cell, PLoS ONE, vol.17, issue.Pt 6, p.17966, 2011.
DOI : 10.1371/journal.pone.0017966.s015

M. Wozniak, A. Mee, and R. Itzhaki, Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques, The Journal of Pathology, vol.27, issue.12, pp.131-138, 2009.
DOI : 10.1002/path.2449

M. Wozniak, R. Itzhaki, S. Shipley, and C. Dobson, Herpes simplex virus infection causes cellular ??-amyloid accumulation and secretase upregulation, Neuroscience Letters, vol.429, issue.2-3, pp.95-100, 2007.
DOI : 10.1016/j.neulet.2007.09.077

R. Piacentini, L. Civitelli, C. Ripoli, E. Marcocci, M. et al., HSV-1 promotes Ca(2+)-mediated APP phosphorylation and Abeta accumulation in rat cortical neurons, Neurobiol Aging, 2010.

S. Santana, M. Recuero, M. Bullido, F. Valdivieso, and J. Aldudo, Herpes simplex virus type I induces the accumulation of intracellular beta-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cells, Neurobiol Aging, 2011.

D. Chiara, G. Marcocci, M. Civitelli, L. Argnani, R. Piacentini et al., APP Processing Induced by Herpes Simplex Virus Type 1 (HSV-1) Yields Several APP Fragments in Human and Rat Neuronal Cells, PLoS ONE, vol.122, issue.Suppl 2, p.13989, 2010.
DOI : 10.1371/journal.pone.0013989.s004

M. Wozniak, A. Frost, C. Preston, and R. Itzhaki, Antivirals Reduce the Formation of Key Alzheimer's Disease Molecules in Cell Cultures Acutely Infected with Herpes Simplex Virus Type 1, PLoS ONE, vol.63, issue.301, p.25152, 2011.
DOI : 10.1371/journal.pone.0025152.t002

W. Wojtowicz, M. Farzan, J. Joyal, K. Carter, and G. Babcock, Stimulation of Enveloped Virus Infection by ??-Amyloid Fibrils, Journal of Biological Chemistry, vol.277, issue.38, pp.35019-35024, 2002.
DOI : 10.1074/jbc.M203518200

S. Soscia, J. Kirby, K. Washicosky, S. Tucker, and M. Ingelsson, The Alzheimer's Disease-Associated Amyloid ??-Protein Is an Antimicrobial Peptide, PLoS ONE, vol.5, issue.3, p.9505, 2010.
DOI : 10.1371/journal.pone.0009505.s002

B. Mcnaull, S. Todd, B. Mcguinness, and A. Passmore, Inflammation and Anti-Inflammatory Strategies for Alzheimer???s Disease ??? A Mini-Review, Gerontology, vol.56, issue.1, pp.3-14, 2010.
DOI : 10.1159/000237873

D. Pratico, Oxidative stress hypothesis in Alzheimer???s disease: a reappraisal, Trends in Pharmacological Sciences, vol.29, issue.12, pp.609-615, 2008.
DOI : 10.1016/j.tips.2008.09.001

T. Valyi-nagy and T. Dermody, Role of oxidative damage in the pathogenesis of viral infections of the nervous system, Histol Histopathol, vol.20, pp.957-967, 2005.

R. Nixon, Autophagy, amyloidogenesis and Alzheimer disease, Journal of Cell Science, vol.120, issue.23, pp.4081-4091, 2007.
DOI : 10.1242/jcs.019265

J. Lambert, B. Grenier-boley, V. Chouraki, S. Heath, and D. Zelenika, Implication of the Immune System in Alzheimer's Disease: Evidence from Genome-Wide Pathway Analysis, Journal of Alzheimer's Disease, vol.20, issue.4, pp.1107-1118, 2010.
DOI : 10.3233/JAD-2010-100018

M. Lipinski, B. Zheng, T. Lu, Z. Yan, and B. Py, Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease, Proceedings of the National Academy of Sciences, vol.107, issue.32, pp.14164-14169, 2010.
DOI : 10.1073/pnas.1009485107

P. Moreira, R. Santos, X. Zhu, H. Lee, and M. Smith, Autophagy in Alzheimer???s disease, Expert Review of Neurotherapeutics, vol.10, issue.7, pp.1209-1218, 2010.
DOI : 10.1586/ern.10.84

R. Itzhaki, W. Lin, D. Shang, G. Wilcock, and B. Faragher, Herpes simplex virus type 1 in brain and risk of Alzheimer's disease, The Lancet, vol.349, issue.9047, pp.241-244, 1997.
DOI : 10.1016/S0140-6736(96)10149-5

I. Kuhlmann, A. Minihane, P. Huebbe, A. Nebel, and G. Rimbach, Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review, Lipids in Health and Disease, vol.9, issue.1, p.8, 2010.
DOI : 10.1186/1476-511X-9-8

R. Itzhaki and M. Wozniak, Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease?, Alzheimer's & Dementia, vol.6, issue.1, pp.83-84, 2010.
DOI : 10.1016/j.jalz.2009.07.136

F. Song, A. Poljak, G. Smythe, and P. Sachdev, Plasma biomarkers for mild cognitive impairment and Alzheimer's disease, Brain Research Reviews, vol.61, issue.2, pp.69-80, 2009.
DOI : 10.1016/j.brainresrev.2009.05.003

D. Lachno, H. Vanderstichele, D. Groote, G. Kostanjevecki, V. et al., The influence of matrix type, diurnal rhythm and sample collection and processing on the measurement of plasma ??-amyloid isoforms using the INNO-BIA plasma A?? forms multiplex assay, The Journal of Nutrition, Health and Aging, vol.16, issue.105, pp.220-225, 2009.
DOI : 10.1007/s12603-009-0062-5

J. Toledo, H. Vanderstichele, M. Figurski, P. Aisen, and R. Petersen, Factors affecting A?? plasma levels and their utility as biomarkers in ADNI, Acta Neuropathologica, vol.305, issue.3, pp.401-413, 2011.
DOI : 10.1007/s00401-011-0861-8

J. Malkin, P. Morand, D. Malvy, T. Ly, and B. Chanzy, Seroprevalence of HSV-1 and HSV-2 infection in the general French population, Sexually Transmitted Infections, vol.78, issue.3, pp.201-203, 2002.
DOI : 10.1136/sti.78.3.201

3. The and . Group, Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population, Neuroepidemiology, vol.22, pp.316-325, 2003.

B. Ohana, M. Lipson, N. Vered, I. Srugo, and M. Ahdut, Novel Approach for Specific Detection of Herpes Simplex Virus Type 1 and 2 Antibodies and Immunoglobulin G and M Antibodies, Clinical and Vaccine Immunology, vol.7, issue.6, pp.904-908, 2000.
DOI : 10.1128/CDLI.7.6.904-908.2000

C. Dufouil, F. Richard, N. Fievet, J. Dartigues, and K. Ritchie, APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: The Three-City Study, Neurology, vol.64, issue.9, pp.1531-1538, 2005.
DOI : 10.1212/01.WNL.0000160114.42643.31

URL : https://hal.archives-ouvertes.fr/inserm-00175952